Heico, Corvus Pharmaceuticals, Tesla And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Heico, Corvus Pharmaceuticals, Tesla And Other Big Stocks Moving Lower In Monday's Pre-Market Session
U.S. stock futures were lower this morning, with the Dow futures falling around 150 points on Tuesday.
今天上午美国股票期货走低,道琼斯指数期货周二下跌约150点。
Shares of HEICO Corporation (NYSE:HEI) fell sharply in today's pre-market trading following fourth-quarter results.
继第四季度业绩公布后,HEICO公司(纽约证券交易所代码:HEI)的股价在今天的盘前交易中大幅下跌。
Heico reported quarterly earnings of 99 cents per share which beat the analyst consensus estimate of 98 cents per share. The company reported quarterly sales of $1.01 billion which missed the analyst consensus estimate of $1.03 billion.
Heico公布的季度收益为每股99美分,超过了分析师共识估计的每股98美分。该公司公布的季度销售额为10.1亿美元,未达到分析师普遍预期的10.3亿美元。
HEICO shares dipped 5.7% to $245.00 in the pre-market trading session.
在盘前交易时段,HEICO股价下跌5.7%,至245.00美元。
Here are some other stocks moving lower in pre-market trading.
以下是其他一些在盘前交易中走低的股票。
- Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) shares dipped 35.7% to $4.74 in pre-market trading. The company announced interim data from the randomized, double-blind, placebo-controlled Phase 1 clinical trial evaluating soquelitinib in patients with moderate to severe atopic dermatitis.
- Fitell Corporation (NASDAQ:FTEL) shares declined 25.2% to $28.72 in pre-market trading after jumping 28% on Tuesday.
- Radiopharm Theranostics Limited (NASDAQ:RADX) declined 22.2% to $3.51 in pre-market trading.
- Southern States Bancshares, Inc. (NASDAQ:SSBK) fell 9.6% to $32.00 in pre-market trading.
- Worthington Steel, Inc. (NYSE:WS) shares dipped 8.6% to $36.00 in pre-market trading ahead of quarterly earnings.
- Structure Therapeutics Inc. (NASDAQ:GPCR) shares fell 6.3% to $29.50 in pre-market trading. Structure Therapeutics announced selection of lead oral small molecule amylin receptor agonist ACCG-2671 for the treatment of obesity.
- Tesla, Inc. (NASDAQ:TSLA) fell 2.1% to $469.95 in pre-market trading. Baird analyst Ben Kallo maintained Tesla with an Outperform and raised the price target from $280 to $480.
- Corvus Pharmicals, Inc.(纳斯达克股票代码:CRVS)股价在盘前交易中下跌35.7%,至4.74美元。该公司公布了这项随机、双盲、安慰剂对照的1期临床试验的中期数据,该试验评估了索克利替尼治疗中度至重度特应性皮炎患者。
- 菲特尔公司(纳斯达克股票代码:FTEL)股价在周二上涨28%后,在盘前交易中下跌25.2%,至28.72美元。
- Radiopharm Theranostics Limited(纳斯达克股票代码:RADX)在盘前交易中下跌22.2%,至3.51美元。
- 南方各州银行股份公司(纳斯达克股票代码:SSBK)在盘前交易中下跌9.6%,至32.00美元。
- 在季度财报公布之前,沃辛顿钢铁公司(纽约证券交易所代码:WS)股价在盘前交易中下跌8.6%,至36.00美元。
- Structure Therapeutics Inc.(纳斯达克股票代码:GPCR)股价在盘前交易中下跌6.3%,至29.50美元。Structure Therapeutics宣布选择领先的口服小分子淀粉样蛋白受体激动剂 ACCG-2671 来治疗肥胖。
- 特斯拉公司(纳斯达克股票代码:TSLA)在盘前交易中下跌2.1%,至469.95美元。贝尔德分析师本·卡洛维持特斯拉的跑赢大盘,并将目标股价从280美元上调至480美元。
Now Read This:
现在阅读这篇文章:
- Top 3 Health Care Stocks That May Explode In Q4
- 第四季度可能爆发的三大医疗保健股
评论(0)
请选择举报原因